LabConnect completes acquisition of A4P to enhance scientific consultancy services
Acquiring Company
LabConnect
Acquired Company
A4P
Johnson CitypharmaceuticalsBiotechnologyHealth CarePharmaceuticalConsultingDescription
LabConnect, a global central laboratory serving the biopharmaceutical industry, has acquired A4P, a scientific consultancy specializing in providing scientific advice, regulatory support, and project management services to the pharmaceutical, biopharmaceutical, and medical device industries. This acquisition aims to enhance LabConnect's services and capabilities in the scientific consultancy arena.
Quick answer
LabConnect is acquiring A4P, announced April 22, 2024. LabConnect is based in Johnson City, Tennessee, United States.
- How much did LabConnect pay for A4P?
- The deal value was not disclosed.
- What does LabConnect do?
- LabConnect is a global company that specializes in Central Laboratory Services, Functional Service Provider (FSP) Solutions, and Data Management for clinical research trials.
- Where are LabConnect and A4P based?
- LabConnect is based in Johnson City, Tennessee, United States.
- Who are the decision-makers at LabConnect?
- Fundz holds 3 contacts at LabConnect. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Other recent acquisitions in pharmaceuticals and Pharmaceutical
Deals where the buyer or target shares a sector with this one, within 45 days, from Fundz verified event records.
- Cycle Pharmaceuticals proposes to acquire Vanda Pharmaceuticals for $8.00 per share (June 6, 2024)
- AbbVie finalizes acquisition of Landos Biopharma, Inc. to advance treatment for ulcerative colitis and Crohn's disease (May 23, 2024)
- LCI completes acquisition of certain assets of Pfizer Pakistan Limited and Pfizer Inc. to enhance pharmaceutical portfolio (May 20, 2024)
- Abbvie To Acquire Landos Biopharma, Further Strengthening Its Portfolio In Inflammatory And Autoimmune Diseases (March 25, 2024)
- ONO completes acquisition of Deciphera Pharmaceuticals to reinforce its oncology portfolio (April 30, 2024)
- ONO Pharmaceutical Co., Ltd. to acquire Deciphera Pharmaceuticals, Inc. for $2.4 Billion, $2.4B (April 29, 2024)
Who to call at LabConnect, and when
When LabConnect changes hands, the new owners review vendors, systems and leadership. That is when the door opens.
- An alert the day LabConnect raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at LabConnect, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at LabConnect. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment LabConnect makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Frequently asked
Who acquired A4P?
A4P was acquired by LabConnect, based in Johnson City. The deal was reported on April 22, 2024. LabConnect is a global company that specializes in Central Laboratory Services, Functional Service Provider (FSP) Solutions, and Data Management for clinical research trials. LabConnect is privately held and operates in pharmaceuticals.
When did LabConnect acquire A4P?
LabConnect's acquisition of A4P was reported on April 22, 2024. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does A4P do?
A4P is a scientific consultancy specializing in providing scientific advice, regulatory support, and project management services to the pharmaceutical, biopharmaceutical, and medical device industries. It is privately held, operating in Biotechnology.
This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.